CTLT announces an agreement to sell its oral solids development and manufacturing facility in Somerset to Ardena.

The site also serves as an oral solids development and small-scale manufacturing facility for the pharmaceutical company, ...

Ardena inks agreement to acquire Catalent’s state-of-the-art facility in Somerset, New Jersey: Ghent, Belgium Tuesday, October 15, 2024, 16:00 Hrs [IST] Ardena, a specialist pha ...

Catalent entered into a definitive agreement to sell its oral solids development and small-scale manufacturing facility in ...

Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...

Catalent, Inc. (CTLT), a provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer ...

Novo Holdings is set to buy one less facility from Catalent as the manufacturer has sold a facility in New Jersey to a ...

Smartee recently held an exclusive workshop in Valencia, where renowned experts Prof. Gang Shen and Dr. Jingting Lu ...

National healthcare leader PAM Health announced plans today to build a freestanding, 42-bed physical medicine and rehabilitation hospital in Boca Raton, Florida.  The hospital will be the organization ...

The FDA-approved Somerset facility employs approximately 200 skilled scientists and technicians and is a Center of Excellence for advanced delivery of oral dosage forms, complementing Ardena's ...

Somerset facility State-of-the art facility for clinical and commercial manufacturing of oral dosage forms. Ghent, Belgium, ...

Catalent (CTLT) sells Somerset, NJ facility to Ardena. Corporate headquarters to shift to new location post-transition.